Emily Chee

General Manager, Americas • Novartis

Emily Chee is the General Manager – Americas for Novartis Gene Therapies.  She has responsibility for the business in the US where Zolgensma was launched in 2019 as well as Canada and Latin America.  Emily has worked with Novartis for close to two decades focused on the Oncology business until two years ago when she shifted to Gene Therapies.  She has also served many Big Pharma and Biotech clients as a management consultant prior to joining Novartis

Also Speaking

Scott Jones

Senior Vice President & Chief Scientific Officer • BioBridge Global

Fabio Fachin

Head of Cell Therapy Process Development, Automation and Digital Technologies • Takeda

Pierre Boulas

Head of Medical Devices and Packaging Development • Biogen

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.